The vaccine business was safely inoculated against higher profits. But innovative therapies and looser government controls may spark an outbreak. Ready for opportunity? May 1, 2006 By:Andrew Pasternak, Adam Sabow, Andrew Chadwick-Jones
Mergers have cut the field of companies with real marketing and manufacturing muscle from 25 to five. The 2004 vaccine market will double by 2009.